Tomoyuki Nagao

Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation

Tomoyuki Nagao, Yasuya Inden, Satoshi Yanagisawa et al. · Heart Rhythm · 2015 · 53 citations

Thrombosis, Cardiovascular Disease, Periprocedural Period +11

Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation

Tomoyuki Nagao, Yasuya Inden, Masayuki Shimano et al. · Pacing and Clinical Electrophysiology · 2014 · 49 citations

Increased expression of the adipocytokine omentin in the epicardial adipose tissue of coronary artery disease patients

Ken Harada, Rei Shibata, Noriyuki Ouchi et al. · Atherosclerosis · 2016 · 46 citations

Inflammation, Metabolic Syndrome, Obesity +15

Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy

Tomoyuki Nagao, Hitomi Suzuki, Syun Matsunaga et al. · EP Europace · 2018 · 42 citations

Coagulation Markers, Dose Strategy, Pharmacotherapy +22

Effects of Bag-mask versus Advanced Airway Ventilation for Patients Undergoing Prolonged Cardiopulmonary Resuscitation in Pre-hospital Setting

Tomoyuki Nagao, Kosaku Kinoshita, Atsushi Sakurai et al. · Journal of Emergency Medicine · 2011 · 32 citations

Neonatal Resuscitation, Cardiopulmonary Resuscitation, Medicine +7